baber/WOPTO huggingface dataset:
Patent NZ-528728-A (NZ)
Title: Use of fatty alcohol ethoxylates as penetrants for insecticidally active neonicotinyls even in very low concentrations
Inventor: ROSENFELDT FRANK
IPC: A01N25/30
Filed: 2002-04-02
Abstract: Described are fatty alcohol ethoxylates of formula (I) wherein m represents average values of 8.0 and 13.0, in addition to average values of 6.0 and 17.0. The fatty alcohol ethoxylates are highly suitable for use as penetration promoters for neonicotinyl insecticidal active ingredients when they are used in amounts contained in commercially available formulations in concentrations of 0.1-30 wt% and the weight ratio of neonicotinyl to fatty alcohol ethoxylate ranges from 1:0.1 to 1:2.0.
Patent NZ-529801-A (NZ)
Title: Compositions and uses of ET743 for treating cancer
Inventor: CVITKOVIC ESTEBAN
IPC: A61K31/495
Filed: 2003-11-26
Abstract: The application discloses the use of ET743 and another drug in the preparation of a medicament for the treatment of a human patient with cancer. The other drug may be an antimetabolic drug, one with antimitotic effects, drugs which target DNA, anti-emetics, steroid analogues, anti-inflammatory drugs and the like. (62) Divided out of 515423
Patent NZ-530595-A (NZ)
Title: Air cleaning device including a metal plate, a heating element and a nozzle to spray the metal plate with water
Inventor: FROMREIDE HANS-JACOB
IPC: B03C3/16
Filed: 2002-06-27
Abstract: An air purification device includes a metal plate upon which a DC voltage (45V) is impressed to attract particles in the air to stick to the plate, a heating element 20 to heat the plate to 5000C, and a nozzle 21 connected to a water supply 22 to spray water on the heated, electrified plate. The metal of the plate is preferably beryllium bronze or copper. The suction unit removes the water vapour from the vicinity of the plate.
Patent NZ-539980-A (NZ)
Title: Masonry wall system including blocks with tongues which form furring ridges
Inventor: MALONE JAMES MARK
Filed: 2005-05-12
Abstract: A masonry wall system 40 includes a number of masonry blocks, each block having two external side walls and being adapted for location, in use, adjacent to further said blocks such that the side walls form at least one wall surface of a wall structure. A number of the blocks include a tongue 8 projecting from a sidewall thereof, wherein, in use, said blocks can be arranged such that a number of the tongues 8 combine to form a number of furring ridges on the wall structure. The ridges may be arranged such that a distance between the centres of a furring ridge and an adjacent furring ridge is greater than a length of the longest of the blocks.
Patent NZ-540433-A (NZ)
Title: Treatment and management graft versus host disease (GVHD) by administering chaperonin 10 (cpn10) to a recipient animal
Inventor: HILL GEOFFREY R
IPC: A61P37/06
Filed: 2003-11-06
Abstract: Provided is the use of a pharmaceutically effective amount of chaperonin 10 (cpn10) or functional derivative thereof in the manufacture of a medicament for the treatment of graft versus host disease (GVID) in an animal, wherein the medicament delays, ameliorates, suppresses or otherwise reduces one or more symptoms of GVHD following transplantation of one or more cells, tissues or organs to the animal. Provided are also an isolated cpn10 protein and corresponding pharmaceutical compositions and a process for preparing an isolated cpn10 protein.
Patent NZ-541651-A (NZ)
Title: Partial and full agonists of A1 adenosine receptors
Inventor: CRISTALLI GLORIA
IPC: C07D473/00
Filed: 2004-02-02
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are A1 adenosine receptor agonists useful in the treatment of atrial fibrillation, supraventricular tachycardia and atrial flutter, congestive heart failure, epilepsy, stroke, diabetes, obesity, ischemia, stable angina, unstable angina, cardiac transplant, myocardial infarction and hyperlipidemia.
Patent NZ-541711-A (NZ)
Title: Human factors authentication using abstract definitions of viewable or audible objects
Inventor: CHEN CHUAN PEI
Filed: 2005-09-28
Abstract: A method of authenticating a user of a fixed or mobile terminal, whereby the user is offered a set of abstract viewable or audible objects, at least one of which falls within the user's abstract definition profile. When the user selects the correct object, a further public code is presented, and the user must enter a specific portion of this, combined with a secret code, to authorise the transaction or access required. The abstract objects and the public code may be transmitted via different communication means.
Patent NZ-543639-A (NZ)
Title: Method for reducing acrylamide in corn-based foods, corn-based foods having reduced levels of acrylamide, and article of commerce
Inventor: TERAS LEE MICHAEL
IPC: A23L5/20
Filed: 2004-06-14
Abstract: Disclosed is a method for the reduction of acrylamide in corn-based food products, corn-based food products having reduced levels of acrylamide, and an article of commerce. In one aspect, the method comprises reducing the level of asparagine in a corn-based food material before final heating (e.g., cooking) by adding an asparagine-reducing enzyme (such as asparaginase) to the food material before heating. In another aspect, the method comprises adding to a corn-based food material an enzyme capable of hydrolyzing the amide group of free asparagine. In yet another aspect, an article of commerce communicates to the consumer that a corn-based food product has reduced or low levels of acrylamide or asparagine.
Patent NZ-545871-A (NZ)
Title: Animal model for protease activity and liver damage
Inventor: KALKERI GURURAJ
IPC: A61K31/4709
Filed: 2004-09-13
Abstract: Provided is a non-human mammal whose liver comprises an expression construct comprising: A) a promoter; B) DNA comprising a nucleotide sequence encoding a viral protease, bacterial protease, or fungal protease; C) DNA encoding a sequence cleaved by the protease; and D) DNA comprising a nucleotide sequence encoding a reporter, wherein A, B, C, and D are operably linked such that C is located between B and D and the DNA is expressed in the liver to produce a protease-reporter fusion protein, and wherein a presence of reporter activity is indicative of activity of the protease. Further provided are vectors for producing such non-human mammals and cells, including hepatocytes, obtained from such animals.
Patent NZ-547252-A (NZ)
Title: Synergistic anti-cancer compositions
Inventor: DORR ROBERT T
IPC: A61K31/396
Filed: 2004-12-08
Abstract: Disclosed is the use of a composition comprising imexon in the manufacture of a medicament for administration in combination with an antineoplastic nucleic acid binding agent for treating cancer in a human patient in need of such treatment, said medicament containing a therapeutically effective amount of said composition to provide a synergistic therapeutic cytotoxic effect in combination with the antineoplastic nucleic acid binding agent.
Patent NZ-547905-A (NZ)
Title: A medical product comprising tiotropium in a moisture-proof container
Inventor: NILSSON THOMAS
IPC: A61K9/00
Filed: 2004-12-02
Abstract: Disclosed is a dose of tiotropium, in a container with an aluminium high barrier seal to prevent moisture reaching the powder, suitable for use in a dry powder inhaler.
Patent NZ-552504-A (NZ)
Title: Improved jamb flashing with acute angle at the free edge
Inventor: ANTICHICH MICHAEL
Filed: 2007-01-09
Abstract: A jamb flashing 10 includes a first plate 11, a flange 12 and a second plate 13. The first and second plates 11, 13 are co-planar, and the plane of the flange 12 is substantially perpendicular to the plane of the plates 11, 13. The free edge 14 of the first plate 11 is turned up to lie at an acute angle X to the plane of the plate 11. The free edge 15 of the plate 13 is upturned. The free edge 16 of the flange 12 is formed as a rounded bead.
Patent NZ-553965-A (NZ)
Title: Double layer forming fabric with high centre plane resistance
Inventor: DANBY ROGER
IPC: D03D11/00
Filed: 2005-09-29
Abstract: Double layer forming fabrics, woven to an overall repeating weave pattern requiring at least 8 sheds in the loom, provide a low drainage area in a notional centre plane between the paper and machine side layers, to resist and retard initial impingement drainage. Transverse binder yarn pairs follow a single combined path interweaving with paper side layer and machine side layer yarns, with long internal floats under at least four paper side layer yarns between exchange points and interlacing points in the machine side layer. The members of the pairs are laterally displaced in relation to each other along the single combined path. The fabric has a total warp fill after heat setting of at least 100%. The drainage areas of the paper side layer and the machine side layers are between 25% and 50%, and the centre plane drainage area is between 8% and 20%.
Patent NZ-556068-A (NZ)
Title: Mesh network of intelligent devices communicating via powerline and radio frequency
Inventor: CREGG DANIEL BRIAN
Filed: 2005-06-01
Abstract: A communication module for use in a system including a plurality of communication modules is disclosed. The communication module comprises circuitry for storing a number, referred to as the module address, designating an address for the communication module. The communication module also comprises circuitry for sending and receiving messages over at least one communications medium and circuitry and software for generating messages and for receiving and deciphering messages. Each of the messages comprises a first number field, referred to as the originator address, designating the module address of the module originating the message; a second number field, referred to as the recipient address, designating the module address of an intended recipient module; a third number field, referred to as the message flags, designating the type of message; a fourth number field, referred to as the maximum retransmission count, designating the maximum times the message can be retransmitted; a fifth number field, referred to as the current retransmission count, designating how many times the message has already been retransmitted; a sixth number field, referred to as the command field, designating an action; and a seventh number field, referred to as the message validator, designating a message integrity validation. The communication module also comprises circuitry and software for determining if a received message has reached all of its intended recipients by inspecting the message flags and by comparing the recipient address to the module address. The communication module further comprises circuitry and software for determining if a received message has already been retransmitted the maximum number of times for that message by comparing the maximum retransmission count and the current retransmission count; and circuitry and software for retransmitting a received message with the current retransmission count altered by one, but only if the received message has not reached all of its intended recipients and has not already been retransmitted the maximum number of times.
Patent NZ-556478-A (NZ)
Title: DR5 antibodies and uses thereof
Inventor: ADAMS CAMELLIA W
IPC: C07K16/28
Filed: 2006-01-31
Abstract: Provided is an anti-DRS antibody comprising mutations in the heavy and light chain of full-length antibody 16E2, or a fragment thereof, wherein: said antibody or antibody fragment has a greater affinity for DRS than full-length antibody 16E2 and is capable of activating or stimulating apoptosis in cancer cells; and the mutations comprise: (i) a set of heavy chain mutations selected from the group consisting of (i) NS3Q, L102Y; (ii) M34L, N53Q, L102Y; (iii) N53Y, L102Y;(iv) M34L, N53Y, L102Y; (v) G33A, N53Q, L102Y; (vi) M34L, N53Y, L102Y; (vii) G33A, N53Q, L102Y; (viii) G33A, N53Y, L102Y; (ix) T28A, N53Q, L102Y; and (x) T28A, NS3Y, L102Y; and (ii) a set of light chain mutations selected from the group consisting of (i) Q24S, G50K, K51D, H95bY; (ii) Q24S, K51A, D92S, S93Y; and (iii) Q24S, K51A, R91A in the amino acid sequence. The antibodies can be used to treat cancer.
Patent NZ-560866-A (NZ)
Title: Zalmanov yellow turpentine emulsion (tonic) for baths containing gum turpentine, castor oil, oleic acid, cocamide DEA and sodium lauryl sulphate
Inventor: DOROKHOVA LOLA
Filed: 2007-08-23
Abstract: Disclosed is an emulsion for adding to the bath containing gum turpentine, castor oil, oleic acid, coconut diethanolamide and sodium lauryl sulphate.
Patent NZ-562451-A (NZ)
Title: Sound reducing polymer interlayers
Inventor: LU JUN
IPC: B32B17/10
Filed: 2006-03-16
Abstract: A polymer interlayer comprising: a first polymer sheet comprising a plasticized poly(vinyl butyral); a second polymer sheet comprising a plasticized poly(vinyl butyral), wherein the amount of plasticizer in said plasticized poly(vinyl butyral) of said second polymer sheet is at least 10 parts per hundred greater than the amount of plasticizer in said plasticized poly(vinyl butyral) of said first polymer sheet, wherein said second polymer sheet has a residual hydroxyl content per weight percentage that is at least 2% lower than the residual hydroxyl content per weight percentage of said first polymer sheet, wherein said first polymer sheet and said second polymer sheet are in direct contact with each other, and wherein said first polymer sheet and said second polymer sheet each have a residual acetate content of less than 5 mol percent; and, a third polymer sheet disposed in direct contact with said second polymer sheet, wherein said third polymer sheet comprising plasticized poly(vinyl butyral) and wherein the amount of plasticizer in said plasticized poly(vinyl butyral) of said second polymer sheet is at least 10 parts per hundred greater than the amount of plasticizer in said plasticized poly(vinyl butyral) of said third polymer sheet.
Patent NZ-563359-A (NZ)
Title: 1,2-Di(cyclic group)substituted benzene derivative
Inventor: KAWAHARA TETSUYA
IPC: A61K31/495
Filed: 2006-06-14
Abstract: Disclosed is a 1,2-di(cyclic)-substituted benzene derivative represented by the general formula (1) or (100), a salt thereof or a hydrate of the compound or salt, which has excellent cell adhesion-inhibitory action or cell infiltration-inhibitory action. Wherein R10 represents a 5- to 10-membered cycloalkyl group which may be substituted; R40 represents a C1-10 alkyl group which may be substituted; n represents an integer of 0, 1 or 2; X1 represents CH or a nitrogen atom; and the remaining substituents are as defined in the specification. Also disclosed is the use of the derivatives as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes.
Patent NZ-563880-A (NZ)
Title: Current sensor for measuring an electrical current in a circuit having a plurality of electrical conductors
Inventor: MONTREUIL MICHEL
IPC: A01K29/00
Filed: 2006-05-10
Abstract: Disclosed is a current sensor (100) for measuring an electrical current in an electrical circuit having an electrical conductor. The sensor comprises of: a magnetic structure (6, 7, 8, 9) for receiving the electrical conductor; a magnetic flux sensor (14, 15, 16) coupled with the electrical conductor; an analog to digital converter; a processor (29); a printed circuit board (31); and a case (1). The magnetic flux sensor is for sensing a magnetic flux generated in the magnetic structure by a current flowing in the electrical conductor, and providing a signal representative of a value of the current at a specific time over a period of time. The analog to digital converter acquires the signal and converts the signal into digital sensor data. The processor receives the digital sensor data, detects an electrical disturbance on the electrical conductor using the value and provides an electrical disturbance signal. The case has an input hole (2, 3, 4, 5) throughout for passing the electrical conductor therethrough and through the magnetic structure such that the current sensor is positionable anywhere along the electrical conductor.
Patent NZ-571533-A (NZ)
Title: Hanger system for concrete building units
Inventor: EDKINS DAVID JOHN
IPC: E04G17/18
Filed: 2008-09-24
Abstract: Disclosed is a hanger for a cementitous building unit. The hanger includes first and second hanger components each with complimentary interlocking portions. The interlocking portions provide vertical height adjustment of the first hanger component relative to the second hanger component. The first hanger component also includes at least one first connecting portion for a tension tie for anchorage within the cementitous building unit.
Patent NZ-575848-A (NZ)
Title: A method and apparatus for provision of temporary conductor tension support in transmission or distribution circuits
Inventor: DEVINE CLIFFORD WILLIAM
IPC: H02G7/04
Filed: 2007-08-29
Abstract: A conductor supporting assembly includes a pair of yokes having a pair of cables extending therebetween in spaced parallel array. Actuators tension the cables so as to selectively draw the yokes toward each other along the cables. Grips cooperate with yokes for mounting the yokes in spaced apart array to and along a conductor segment of a conductor to be serviced so as to extend the conductor segment along and substantially medially between the yokes. The drawing of the yokes toward each other thereby de-tensions the conductor segment to allow for repair or service.
Patent NZ-577446-A (NZ)
Title: A single piece window frame for holding two spaced apart sheets and having a channel to collect moisture
Inventor: NEWTON MATTHEW AUSTIN CHARLES
IPC: E06B1/04
Filed: 2011-03-04
Abstract: Disclosed is a frame member which has a transverse cross sectional profile which includes a primary section and a bridging section projecting substantially orthogonally from a middle section of the primary section so as to leave a portion of the primary section on either side of the bridging section. The bridging section has a secondary section extending substantially orthogonally in one direction away from the bridging section. The secondary section is in an opposed relationship with a portion of the primary section and forms a receiving region in between the primary and secondary sections. The bridging section is split by a longitudinal channel which opens towards the receiving region.
Patent NZ-577764-A (NZ)
Title: Inhalation device accommodating a plurality of drug powder doses
Inventor: HERDER MARTIN
IPC: A61M15/00
Filed: 2007-12-21
Abstract: An inhalation device for powder drugs which has improved use properties, particularly advanced moisture protection while in use, is disclosed. The inhalation device has at least one storage chamber (13) for accommodating a plurality of drug powder doses and a dosing device which includes at least one dosing slider which moves with a translatory movement in a dosing slider passage (16) at least from a filling position into an emptying position. The inhalation device further includes a device for inhalation-triggered automatic movement of the dosing slider from its filling position into the emptying position and a return device for automatic movement of the dosing slider back into the filling position.
Patent NZ-578368-A (NZ)
Title: Extraction and purification of lipoxygenase from soy beans
Inventor: PATANE MICHAEL
IPC: C07K1/14
Filed: 2007-12-20
Abstract: Disclosed is a process for purifying lipoxygenase from soy beans including the steps of: a) extracting lipoxygenase from soy beans into an alkaline aqueous solution to form an extract; b) heating the extract and providing the extract with a pH below the isoelectric point of lipoxygenase to selectively precipitate compounds from the extract while retaining lipoxygenase in solution, to form an acidic extract; c) separating the precipitated compounds from the acidified extract, to provide a purified extract of lipoxygenase.
Patent NZ-579097-A (NZ)
Title: barrier enclosure with movable barrier arm
Inventor: SMITH COLIN
IPC: E01F13/00
Filed: 2009-08-18
Abstract: A barrier for selectively preventing vehicular access to unauthorised areas, the barrier includes i) a substantially horizontally extending elongate housing situated on at least one vertical extending support means 15 such that the elongate housing is in a raised position a distance above the surface to which the support means 15 is situated, ii) at least one elongate beam 12 having at least one roller 18 attached to the elongate beam 12 so as to support and allow the elongate beam 12 to slide relative to the elongate housing, wherein the elongate beam 12 is movable between a closed position and an open position such that when the elongate beam 12 is in the open position the elongate beam 12 is fully housed within the elongate housing and when the elongate beam 12 is in the closed position the beam 12 extends longitudinally outwardly from the elongate housing, and iii) a drive means 26 for moving the elongate beam 12 between the closed and open positions.
Patent NZ-584216-A (NZ)
Title: Vaginal delivery system
Inventor: TALLING CHRISTINE
IPC: A61K9/00
Filed: 2008-11-19
Abstract: Disclosed is an intravaginal delivery system for the controlled release of therapeutically active substances or prodrugs thereof over a prolonged period of time, the system comprising at least one compartment, said one or each 5 compartment comprising a core and a membrane encasing the core, said core and membrane comprising a same or different polymer composition, wherein at least one compartment comprises drospirenone and at least one compartment, which may be the same or different from the one comprising drospirenone, comprises an estrogen, and wherein the polymer composition comprises poly(dimethylsiloxane) based elastomer which comprises poly(alkylene oxide) groups.
Patent NZ-593020-A (NZ)
Title: Method for removal of hydrogen sulfide from geothermal steam and condensate
Inventor: HARLESS MICHAEL L
IPC: B01D53/52
Filed: 2009-12-07
Abstract: 593020 Disclosed is a method for removal of hydrogen sulphide (sulphide) from geothermal steam in a condenser comprising the steps of: injecting acrolein (prop-2-enal) in an effective amount into cooling water sprayed into said condenser to provide within said condenser a curtain of fine water droplets containing said acrolein in an aqueous phase; allowing said fine water droplets containing said acrolein in an aqueous phase to react with vapor phase hydrogen sulfide in said geothermal steam in said condenser to produce 4- hydroxyl-tetrahydro-2H-triopyran-3-carbaldehyde and beta, beta' - thiodipropionaldehyde byproducts; and disposing of said byproducts in a non-volatile aqueous phase.
Patent NZ-594208-A (NZ)
Title: Pharmaceutical compositions resistant to abuse
Inventor: TYGESEN PETER HOLM
IPC: A61K9/28
Filed: 2010-02-05
Abstract: Disclosed herein is a shell for an abuse-resistant pharmaceutical composition, comprising an outer shell wall having an inner surface and extending from a first end to a second end, the outer shell wall having a first opening at the first end and a second opening at the second end, the first and second opening having an area in the range from about 1mm 2 to about 100 mm2, wherein the outer shell wall has a maximum thickness in the range from 1.3 mm to 7 mm, and the shell having a length in the range from 4 mm to 20 mm.
Patent NZ-598393-A (NZ)
Title: Modulators of atp-binding cassette transporters
Inventor: HADIDA RUAH SARAH S
IPC: A61K31/47
Filed: 2005-06-24
Abstract: Disclosed are N-(4-tert-butyl-2-phenyl-5-hydroxyphenyl)-1,4-dihydro-4-oxo-quinoline-3-carboxamide derivatives as represented by the general formula V-A-I, or a pharmaceutically acceptable salt thereof, wherein: WRW2 is a phenyl ring optionally substituted with up to three substituents selected from -OR’, -CF3, -OCF3, SR’, S(O)R’, SO2R’, halo, CN, -COOR’, -(CH2)OR’, CH2CN, optionally substituted phenyl or phenoxy, -N(R’)(R’), -NR’C(O)OR’, -NR’C(O)R’, -(CH2)2N(R’)(R’), or -(CH2)N(R’)(R’); WRW4 is straight or branched alkyl; WRW5 is OH; R’ is independently selected from hydrogen or an optionally substituted group selected from an aliphatic group, cycloalkyl or phenyl; X is a bond; and RX is hydrogen.